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Background: Glucocorticoid has been used extensively in clinical applications, because of its several pharmacologic
actions, which include immunosuppression, anti-inflammation, anti-shock, and relief of asthma. However, the
long-term or high-dose application of glucocorticoid can induce adverse effects such as osteoporosis, which is
known in this case as glucocorticoid-induced osteoporosis (GIOP). It is a secondary osteoporosis that results in easy
fracturing, and even disability. Therefore it became a thorny issue.
Methods: The rat model of glucocorticoid-induced osteoporosis (GIOP) was replicated to isolate BMSCs. Rats were
assigned into four groups: normal, normal induction, GIOP, and GIOP induction. The growth cycle was monitored
by using flow cytometry. Osteogenic differentiation was compared by using alkaline phosphatase (ALP) staining
with a modified calcium cobalt method. The quantitative detection of osteoprotegerin and the receptor activator
of nuclear factor kappa-B ligand (RANKL) was conducted by using enzyme-linked immunoassay. Finally, renal Klotho
mRNA expression was assessed by using RT-PCR.
Results: BMSC proliferation was reduced in GIOP rats. The ALP-positive expression of normal BMSCs to the osteogenic
induction solution was stronger than that of BMSCs from GIOP rats (P < 0.01). Osteoprotegerin expression was
significantly higher in the normal induction group than in the normal, GIOP (P < 0.01), and GIOP induction groups
(P < 0.05). RANKL expression was significantly higher in the normal induction group than in the other groups (P < 0.01)
and significantly higher in the normal group than in the GIOP and GIOP induction groups (P < 0.01). RT-PCR analysis
showed that renal Klotho mRNA expression was significantly reduced in the GIOP group compared with the normal
group (P < 0.01).
Conclusion: BMSC proliferation, osteogenic differentiation, and reactive activity to an osteogenic inductor were
reduced in GIOP rats. Klotho mRNA expression decreased during GIOP induction.
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Osteoporosis (OP) is a systemic skeletal disease characte-
rized by low bone mass, increased bone fragility, and high
morbidity and mortality. In China, OP is one of three age-
related diseases included in the National Key Research
Fund. In the United States, the treatment of fractures
caused by OP is estimated to cost USD 15 billion [1]. OP
can increase the incidence of fractures and is one of the* Correspondence: dahxcn@yeah.net
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unless otherwise stated.main complications of glucocorticoid (GC) application
[2]. This study was carried out in strict accordance with
the recommendations in the Guide for the Care and Use
of Laboratory Animals of the National Institutes of
Health. The animal use protocol has been reviewed and
approved by the Institutional Animal Care and Use
Committee (IACUC) of Liaoning Medical University.
Osteoblast (OBs) and fat cells originate from bone
marrow-derived mesenchymal stem cells (BMSCs) and
have the same cell phenotype. When conditions are
met, OBs and fat cells increase/decrease inversely [3].
GCs promote and inhibit the differentiation of BMCSstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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coupling imbalance between OBs and osteoclasts. This
phenomenon causes bone loss and OP [4]. Therefore,
the development of specific drugs to reduce bone turn-
over rate has become an urgent task. The present study
aims to investigate the influence of GC on the osteogenic
differentiation of rat BMSCs and determine the patho-
logical mechanism of GCs to establish a foundation for
the prevention of glucocorticoid-induced osteoporosis
(GIOP) by Chinese medicine.
Methods
Animals
A total of 20 Sprague–Dawley rats (half male and half
female) aged eight months and weighing 350 ± 10 g were
provided by the Laboratory Animal Center of Liaoning
Medical University. The rats were assigned equally into
four groups: normal (normal BMSCs from rats), normal
induction (normal BMSCs from rats + osteogenic induc-
tion solution [5,6]), GIOP (BMSCs from GIOP rats), and
GIOP induction (BMSCs from GIOP rats + osteogenic
induction solution) groups.
Establishment of the GIOP model
GCs could directly inhibit the osteogenic activity of
osteoblasts and reduce the bone formation, leading to loss
of bone mass [7]. According to reported methods [8,9], 10
of 20 rats were randomly selected to establish the GIOP
models. Dexamethasone was applied into the hind limbs of
rats by intramuscular injection at concentrations of
2.5 mg/kg twice a week for 9 consecutive weeks.
Isolation, cultivation, and subcultivation of BMSCs
A constant volume of the cell culture solution was main-
tained at 100 mL under sterile conditions. The solution
was fully mixed and stored at 4°C. An osteogenic differen-
tiation induction solution composed of 10−8 mol/L Dex,
50 μmol/L Vitamin C, 10 mmol/L β-GP, and 10% fetal
bovine serum was used to isolate and culture the BMSCs
following the whole bone marrow adherence method. Rats
were dipped in 75% ethanol for 20 min and anesthetized
with chloral hydrate. Under aseptic conditions, the bila-
teral lower limb femurs of rats were obtained followed by
the removal of attached fatty tissues, connective tissues,
and periosteum. The femurs were placed in a small aseptic
beaker and then moved on a super clean bench. There-
after, the femurs were stored on a sterile culture dish.
After washing with PBS, the bilateral mummification ends
in the femur were resected. A total of 5 ml G-DMEM con-
taining 10% FBS was mixed with 0.5 ml of heparin. The
marrow cavities of the femurs were rinsed by the mixed
solution for three to four times. The flushing fluid was
fully beaten followed by cell resuspension with G-DMEM
containing 10% FBS. The cells (density was adjusted to1 × 106 cells/ml) were inoculated in a 25 cm2 culture
bottle and were then cultured (37°C, 5% CO2, saturated
humidity). The medium was changed every three days.
After the adherent cells reached 80% to 90% fusion, the
culture medium was abandoned followed by washing with
PBS for three times. The preheated (37°C) digestion liquid
containing 0.25% trypsin and 0.02% EDTA was used for
digestion at room temperature followed by passage with a
ratio of 1:2.
Determination of BMSC growth cycle and osteogenic
differentiation capacity
The passage 3 growth cycle of BMSCs from normal and
GIOP rats was monitored by using flow cytometry.
Osteogenic differentiation was evaluated by using alka-
line phosphatase (ALP) staining with a modified calcium
cobalt method. Passage 3 BMSCs from normal and GIOP
rats were seeded in a 24-well culture plate at a density
of 5 × 104 cells/mL with 6 parallel wells in each group.
The induction groups were incubated with the osteo-
genic differentiation induction solution with a final vo-
lume of 2.5 mL in each well. The solution was replaced
every 3 days for 21 consecutive days. Glass slides were
harvested for ALP staining at 7, 14, and 21 days. To
quantify the number of ALP-positive cells and the total
number of cells and calculate the positive staining rate,
10 non-overlapping fields of view were randomly selected
under a light microscope.
Determination of OPG and RANKL expression
On day 14, cell supernatants were harvested from each
induction group and stored at −20°C. OPG and receptor
activator of nuclear factor kappa-B ligand (RANKL) expres-
sions were determined by using ELISA (ELISA USAR&D
Systems, USA).
Determination of Renal Klotho mRNA expression
RT-PCR primers and RNA PCR Kit (AMV) Ver.3.0 kit
were sourced from Takara, Dalian (China). The 600 bp
DNA ladder marker was obtained from Tianze Genetic
Engineering Co. Ltd. (China). Primers were designed by
using Primer Premier 5.0 according to the rat Klotho (KL)
and β-actin gene sequences determined in GenBank,
The PCR products of KL and β-actin gene were 383
and 277 bp in length,respectively. The total RNA was
extracted according to the Trizol Reagent instructions
(Invitrogen, USA). The first cDNA strand was synthe-
sized according to the Takara RT-PCR kit instructions.
The reaction conditions were as follows: 42°C for
30 min→ 99°C for 5 min→ 5°C for 5 min→ store at
4°C. The PCR-amplified products were detected by
electrophoresis at 9 V/cm (90 V) for 1 hour with
3 μL of 100 bp standard molecular weight DNA ladder
marker as a reference.
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Experimental data were expressed as mean ± SD and
analyzed by using SPSS 11.0 software. The elec-
trophoresis results were analyzed by using Fluor Chem V
2.0 gel imaging analysis software (Gene Genus, Syngene
Inc., USA).Figure 1 BMSC growth cycles for normal and GIOP rats. (A) Normal grResults
Comparison between the BMSC growth cycles for normal
and GIOP rats
Approximately 10.10% and 5.82% of BMSCs in normal
and GIOP rats were arrested at S + G2 +M, respectively
(Figure 1A and B).oup; (B) GIOP group.
Table 1 Comparison between the ALP-positive rates in different groups (x ± s, n = 3)
Group 7 d 14 d 21 d
Normal 2.3332 ± 0.5774▲▲△△ 7.0011 ± 0.9882▲▲△△ 8.3289 ± 1.1632▲▲△△
Normal induction 20.3333 ± 1.5275 30.3245 ± 1.5268 30.3245 ± 1.5268
GIOP 1.6668 ± 0.5742▲▲△△ 2.3298 ± 0.5699◆▲▲△△ 3.0324 ± 1.0349◆▲▲△△
GIOP induction 12.6659 ± 0.5543▲▲ 21.2969 ± 2.1375▲▲ 31.6596 ± 1.5468▲▲
◆P < 0.05, ◆◆P < 0.01, vs. normal group; ▲P < 0.05,▲▲P < 0.01, vs. normal induction group; △P < 0.05, △△P < 0.01, vs. GIOP induction group.
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The ALP-positive rates at the 7th, 14th, and 21st days in
the normal induction group were significantly higher than
the normal and GIOP groups, respectively (P < 0.01)
(Table 1 and Figures 2 and 3). The ALP-positive rates at
the 7th and 14th days in the normal induction group were
also significantly higher than the GIOP induction group
(P < 0.01), except for the 21st day of incubation (P > 0.05).
The ALP-positive rates at the 7th, 14th, and 21st days in
the GIOP induction group were significantly higher than
in the normal and GIOP groups (P < 0.01). The ALP-
positive rates at the 14th and 21st days in the normal
group were significantly higher than in the GIOP group
(P < 0.01). These results indicated that the ALP-positive
expression in normal and GIOP rats increased with the
action of the osteogenic inducer; no obvious differences
were observed in the responses of rats in these two groups
to the osteogenic inducer at the 21st day.
Comparison between OPG and RANKL expression
OPG expression was significantly higher in the normal
induction group than in the normal, GIOP (P < 0.01),
and GIOP induction groups (P < 0.05). OPG expression
was significantly higher in the GIOP induction group than
in the GIOP (P < 0.01) and normal groups (P < 0.05). No
significant difference was found between the normal and
GIOP groups (P > 0.05).
RANKL expression was significantly higher in the nor-
mal induction group than in the other groups (P < 0.01).
Furthermore, RANKL expression was significantly higher
in the normal group than in the GIOP and GIOP induc-
tion groups (P < 0.01). RANKL expression was higher inFigure 2 Osteoblasts after culturing for 14 days (×100). (A) Normal indthe GIOP induction group than in the GIOP group but no
significant differences were observed (P > 0.05; Table 2).
Comparison between renal Klotho mRNA expressions in
different groups
Renal tissues from each group were amplified by using
target gene and internal reference primers. Two bands
with 383 and 277 bp were found as expected (Figure 4).
Results from the image analysis software showed that
renal KL mRNA expression was significantly reduced in
the GIOP group compared with the normal group (P < 0.01).
Table 3 shows that KL mRNA expression was significantly
decreased during GIOP.
Discussion
After the transplantation of BMSCs in the GIOP rats,
the growth rate of a large proportion of adipocytes and
primary cells at three, four, five, and eight days was
slower than the growth rate of primary cells from
normal rats. Moreover, BMSCs from GIOP rats were
worse than the BMSCs from normal rats with poor
refraction. Approximately 10.10% of BMSCs in the nor-
mal rats were arrested at S + G2 +M but only 5.82% of the
BMSCs from the GIOP rats were arrested at S + G2 +M.
Thus, the proliferation of BMSCs from GIOP rats was
worse than the proliferation of normal cells.
Serum osteogenic differentiation ALP is an endocellu-
lar enzyme that can be used to evaluate the degrees of
osteogenic differentiation of various cells and OB func-
tions. Moreover, ALP serves as the relative specific index
of the activity of OBs and the capacity of bone tissue
calcification [10].uction group; (B) GIOP group.
Figure 3 Comparison between the ALP-positive rates in different groups for 21 days (×400). (A) Normal group; (B) Normal induction
group; (C) GIOP group; (D) GIOP induction group.
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a superfamily of tumor necrosis factor receptors and li-
gands. They form the RANKL–RANK–OPG axis, which
is the final pathway in the regulation of bone absorption
and in vitro calcium ion balance, and plays a key role in
bone formation and bone resorption coupling [11,12]. A
variety of bone metabolism factors regulate bone forma-
tion through this axis. Studies demonstrated that OPGs
isolated from humans and rats were 94% homologous
and that OPG was mainly produced by OBs in bone tis-
sues [3]. Further studies showed that OPG could inhibit
osteoclast formation, differentiation, and survival and
could induce OB apoptosis [4]. Patients with bone meta-
bolic diseases were observed with RANK and OPG muta-
tions [13]. GCs at physiological concentrations enhance
osteoclast function by increasing the expression of para-
thyroid hormone receptors, whereas excessive physio-
logical doses of GCs promote an increase in theTable 2 Comparison between OPG and RANKL expression
in different groups (x ± s, n = 5)
Group OPG (ng/ml) RANKL (pmol/l)
Normal 16.3092 ± 0.8425▲▲△ 3.0708 ± 1.2391▲▲
Normal induction 23.8044 ± 1.7818 5.0082 ± 1.0355
GIOP 14.1432 ± 2.6551▲▲△△ 1.6027 ± 0.1123◆◆▲▲
GIOP induction 20.1376 ± 3.0025▲ 2.0739 ± 0.2375◆◆▲▲
◆P < 0.05, ◆◆P < 0.01, vs. normal group; ▲P < 0.05, ▲▲P < 0.01, vs. normal
induction group; △P < 0.05, △△P < 0.01, vs. GIOP induction group.RANKL/OPG ratio, thus accelerating osteoclast gene-
ration and aggravating osteoclasia [14].
In this study, we measured ALP, OPG, and RANKL
expressions in BMSCs from normal and GIOP rats in
the presence or absence of osteogenic induction to
compare the osteogenic differentiation capacity in the diffe-
rent groups.
The ALP-positive expression rate results showed that
the ALP-positive rates at 7, 14, and 21 days were signifi-
cantly higher in the normal induction group than in the
other groups (P < 0.01). The ALP-positive expression
rates at 7, 14, and 21 days were significantly higher in
the GIOP induction group than in the normal and GIOP
groups (P < 0.01). Moreover, at 14 and 21 days, the ALP-
positive rate was significantly higher in the normal group
than in the GIOP group (P < 0.05). These results indicated
that in the presence of osteogenic inductor, ALP-positive
expression increased in BMSCs from both normal and
GIOP rats. BMSCs from normal rats showed stronger
reactive activity toward the inductor than BMSCs from
GIOP rats.
OPG expression in the normal induction group was
significantly higher than in the normal, GIOP (P < 0.01),
and GIOP induction groups (P < 0.05). Moreover, OPG
expression in the GIOP induction group was signifi-
cantly higher than in the GIOP (P < 0.01) and normal
groups (P < 0.05). RANKL expression was significantly
higher in the normal induction group compared with
Figure 4 Electrophoresis of renal Klotho mRNA expression detected by RT-PCR. A) β-actin gene (277 bp); B) KL gene (383 bp). M: DNA
Marker DL 600 bp; lanes 1 and 2: normal group; lanes 3 and 4: GIOP group.
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significantly higher in the normal group compared than
in the GIOP and GIOP induction groups (P < 0.01).
These findings indicated that the osteogenic inductor
could stimulate OPG and RANKL expression.
KL is associated with aging and was discovered by
Kuro-o et al. [15]. The Kl gene in humans and mice are
located in chromosome 13 (13 q12) and exhibits high
homology (83%) [16]. KL is mainly distributed in the
kidneys and brain choroid. KL gene mutation or deletion
can result in various phenotypes similar to human aging,
such as shortened life span, arteriosclerosis, reduced
immune function, and osteoporosis [17]. However,
excessive KL expression or exogenous KL supplementa-
tion for KL-knockout mice can delay or improve aging
symptoms [18]. In the experiments of the current study,
renal KL mRNA expression was significantly reduced in
the GIOP group compared with the normal group (P <
0.01), thus indicating that KL mRNA expression signifi-
cantly decreased during GIOP. The GC-induced reduc-
tion of KL mRNA expression may be involved in the
molecular mechanism of bone metabolism.
The results of this study were consistent with previ-
ously reported results. In future studies, we will prepare
drug-containing sera intervened by kidney reinforcing
and marrow-benefiting Chinese medicine to investigate
the effects of different blood collecting times and drug-
containing sera at different concentrations on the pro-
liferative activity of rat BMSCs based on ALP. We
will also determine the optimal BMSC proliferation-Table 3 Influence of glucocorticoid on Klotho mRNA
expression (x ± s)
Normal group GIOP group
Klotho 736 874 538 625
β-actin 1047 1032 1028 1040
Klotho/β-actin 0.702961 0.846899 0.523346 0.600962
x 0.7765 ± 0.1040 0.5622 ± 0.5657◆◆
◆P < 0.05, ◆◆P < 0.01, vs. normal group.promoting dose and bone-directed differentiation con-
centration of drug-containing sera. We will use the
optimal concentration to explore the possible mecha-
nism of kidney-reinforcing Chinese medicine during
the osteogenic differentiation of BMSCs.
Conclusion
BMSC proliferation, osteogenic differentiation, and re-
action capacity were decreased by the osteogenic inducer.
The expression of the KL gene was significantly reduced
during the process of GC-induced GIOP germination.
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